Medtronic gets creative with device pricing in India; FDA launches MedWatch app;

 @FierceMedDev: Edwards slashes projections despite Q1 growth. Story | Follow @FierceMedDev

 @MarkHFierce: Breaking news about a French device maker at BIO in Chicago. Article | Follow @MarkHFierce

 @DamianFierce: GE's diagnostics imaging is in high demand, and now the company's teaming up with Eisai on Alzheimer's. More | Follow @DamianFierce

> Medtronic ($MDT) is scaling up its monthly installment payment plan in India in an effort to increase sales in a market that often struggles to pay for innovative devices. Article

> The FDA has issued draft guidance to help distinguish a medical device recall from a product enhancement, and has outlined reporting requirements for both. Item

> SynapDx began a 660-child, 20-site clinical study designed to evaluate its blood test for early autism diagnosis. Release

> Researchers are advancing new concepts for microrocket medical devices that can operate inside the body, fueling themselves as they deliver drugs or perform other functions. Story

> Proper checks and tougher regulations could have prevented the PIP breast implant scandal in Europe from affecting so many women, health experts believe. Story

> The FDA slapped Class I recall status on GE Healthcare's ($GE) Giraffe OmniBed and incubator, both products used for newborn babies. Recall notice

> The FDA now has MedWatcher, a downloadable mobile app that lets people submit voluntary reports of major medical device problems to the FDA using their smartphone or tablet. FDA info

Biotech News

 @FierceBiotech: Trending on Stemcell transplant heals mouse brains with neurological deficits. More | Follow @FierceBiotech

 @RyanMFierce: Israel's Treato, analyzing social for pharma, found $14.5M from OrbiMed, New Leaf and Reed Elsevier PR. Story | Follow @RyanMFierce

> AstraZeneca, Aussie biotech outfit ally in $240M-plus discovery deal. More

> Merck scores 'breakthrough' status from FDA for immunotherapy against melanoma. Story

> OPKO Health to acquire Prolor Biotech for $480M. Article

Pharma News

 @FiercePharma: More on GSK's first-quarter numbers to come. For now, sales down 2% to £6.5 bn. Release | Follow @FiercePharma

 @EricPFierce: FDA thinks a computer system can help it identify which plants are at most risk & should top list for inspections. More | Follow @EricPFierce

> Busy Novartis announces layoffs, taps new CFO, and slashes chairman's pay. More

> Feds nail key player in counterfeit Avastin probe. Story

> Feds sue 'repeat offender' Novartis in Myfortic kickback scheme. Article

Drug Delivery News

 @MichaelGFierce: Researchers reverse Parkinson's damage with nasal gene delivery. Article | Follow @MichaelGFierce

> New delivery combo for proven breast cancer drug boosts performance. More

> Bacteria deliver radioactive drugs to treat pancreatic cancer. Story

> AstraZeneca, Bind team up for cancer drug delivery. Item

> Civitas' inhaled Parkinson's drug promises novel delivery with positive PhII results. Article

> Cornell nanosized 'dots' for diagnostics may now deliver drugs. More

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.